ClinicalTrials.gov
public full text
Public Domain
Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder
The aim of this 2-stage, 3-site study is to investigate the effectiveness and safety of a combination of extended-release depot naltrexone plus extended-release bupropion as a potential pharmacotherapy for methamphetamine (MA) use disorder.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder#846973
- Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1#874018
- Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1#968030
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3#994775
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2#886460
Record · ID 849853
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive